Using Cystine Knot Proteins as a Novel Approach to Retarget Oncolytic Measles Virus
Modified measles virus (MV) has effective oncolytic activity preclinically and is currently being investigated in clinical trials for various types of cancer. We investigated the use of cystine knot proteins (CKPs) to direct MV activity. CKPs are short polypeptides that bind their targets with high...
Main Authors: | Sangeet Lal, Corey Raffel |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-12-01
|
Series: | Molecular Therapy: Oncolytics |
Online Access: | http://www.sciencedirect.com/science/article/pii/S237277051730044X |
Similar Items
-
Measles Virus as an Oncolytic Immunotherapy
by: Christine E. Engeland, et al.
Published: (2021-02-01) -
Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus
by: Hill, C, et al.
Published: (2021) -
HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses
by: Laura Menotti, et al.
Published: (2018-06-01) -
Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus
by: Claudia Hill, et al.
Published: (2021-06-01) -
Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine
by: Hutzen Brian, et al.
Published: (2012-11-01)